Brightgene Bio-medical Technology Co. Ltd. Class ASSE: 688166

Announcement on Voluntary Disclosure on the Acceptance of New Drug Application for BGM0504 Injection for Weight Loss Indication

· Issued by Brightgene Bio-medical Technology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure on the Acceptance of New Drug Application for BGM0504 Injection for Weight Loss Indication

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis